Inside this Issue
- Additive IOP-Lowering Effects of the Rho Kinase Inihibitor Ripasudil (K-115) Combined With Timolol or Latanoprost
- Development of Corneal Endothelial Abnormalities Following SLT
- Fluorescein Angiography and OCT in Myopic CNV
- Routine vs. As-Needed Bevacizumab With 12 Weekly Assessment Intervals for Wet AMD
To subscribe to our optical e-newsletters and receive them via e-mail, click here.
Copyright© 2000 - 2015 Jobson Medical Information LLC unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.